Sign in

Tisento Therapeutics

@tisentotx.bsky.social
28 followers 50 following 72 posts

To those lacking effective treatment options: We hear you. And we are relentlessly driving toward much-needed solutions. #MELAS #MitochondrialDisease

PostsRepliesMedia
Tisento Therapeutics @tisentotx.bsky.social · 20/09/2026
Today is the last day of #WorldMitoWeek2026 – but the impact and momentum keep growing, and more people are finding connection, support, and hope. #PuttingMitoOnTheMap #MitochondrialDisease #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 19/09/2026
We’re thrilled to see so many buildings lit up green for #MitochondrialDiseases tonight! This vibrant global display raises awareness, sparks important conversations, and shows support for the mito community. #WorldMitoWeek2026 #PuttingMitoOnTheMap @MitoAware #Biosky
001
Tisento Therapeutics @tisentotx.bsky.social · 18/09/2026
Progress for #MitochondrialDisease depends on collaboration. That’s why we’re dedicated to listening to and partnering with patients, families, clinicians, advocates, and patient orgs. Together, we’re #PuttingMitoOnTheMap. #WorldMitoWeek2026 @MitoAware #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 17/09/2026
#PuttingMitoOnTheMap starts with people – speaking up, sharing info, elevating patient voices. We’re proud to support the advocacy groups across the globe who are working tirelessly to ensure mito is recognized. #WorldMitoWeek2026 #MitochondrialDisease #Biosky
021
Tisento Therapeutics @tisentotx.bsky.social · 16/09/2026
#MitochondrialDisease can affect any organ, at any age, with a wide range of symptoms, making it one of the most challenging conditions to recognize. But better awareness creates opportunities for meaningful and lasting change. @MitoAware #WorldMitoWeek2026 #PuttingMitoOnTheMap #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 15/09/2026
#DidYouKnow: There are hundreds of #MitochondrialDiseases, many of which are individually rare. Collectively, approximately 1.5 million people worldwide live with mito. We’re focused on #MELAS. #WorldMitoWeek2026 #PuttingMitoOnTheMap #Biosky www.tisentotx.com/mito-disease...
010
Tisento Therapeutics @tisentotx.bsky.social · 15/09/2026
It’s #WorldMitoWeek2026! We’re energized by the opportunity to join the global advocacy community to raise awareness of these challenging diseases. This year we’re focused on #PuttingMitoOnTheMap, making mito more visible globally and connecting people across borders. #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 09/09/2026
Check out this #UMDF video to hear Brooke’s #MELAS story, told by her parents Bronya and Neil. Her long journey to a correct diagnosis began after a stroke-like episode as an adult. Brooke’s story inspires our work. #MitochondrialDisease #WeHearYou #ICYMI #Biosky www.umdf.org/melas/
000
Tisento Therapeutics @tisentotx.bsky.social · 31/08/2026
Meet Patricia, living with #MELAS, in the #UMDF “Our MELAS Story” video series. We are dedicated to understanding what matters most to those with this rare #MitochondrialDisease so we can work to improve the lives of people like Patricia. #WeHearYou #Biosky www.umdf.org/melas/ #ICYMI
010
Tisento Therapeutics @tisentotx.bsky.social · 25/08/2026
Chelsea has faced many challenges on her journey with #MELAS, and her mom Alysia supports and advocates for her every step of the way. Hear the Hauner family’s powerful story in this #UMDF video: www.umdf.org/melas/ #MitochondrialDisease #Biosky #ICYMI
000
Tisento Therapeutics @tisentotx.bsky.social · 19/08/2026
Meet the Sterchi family and find out how Steve and Jamie are supporting their son Brady in his #MELAS journey. The #UMDF video series shares Brady’s diagnostic odyssey and how this rare #MitochondrialDisease impacts the family’s daily lives. #Biosky www.umdf.org/melas/ #ICYMI
001
Tisento Therapeutics @tisentotx.bsky.social · 13/08/2026
Last year, we partnered with #Mitocon to share stories of those impacted by #MELAS. It was a privilege to get to know Roberto and Anna, who have been married for 30+ years. See their story (Italian w/ English subtitles): youtu.be/mwkczr_QDxg #MitochondrialDisease #Biosky #ICYMI
000
Tisento Therapeutics @tisentotx.bsky.social · 04/08/2026
Last year, we partnered with #Mitocon to share stories of those impacted by #MELAS. We were honored to get to know Morena, retired nurse and mom, and learn more about her journey. Watch here (Italian w/ English subtitles): youtu.be/bFciPejLNPg #Mitochondrial Disease #Biosky #ICYMI
010
Tisento Therapeutics @tisentotx.bsky.social · 22/07/2026
What’s on your #SummerReads list? We’re adding “The Donkey and the Cart” – by Charles A. Mohan Jr., founder of #UMDF, coming soon. We’re looking forward to learning more about UMDF’s grassroots beginnings & honoring the legacy of his daughter Gina. #MELAS #MitochondrialDisease #SummerReads #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 22/06/2026
That’s a wrap on #MitoMed! We’re grateful to the #UMDF for bringing everyone together, and we’re already looking forward to next year! #MitochondrialDisease #MELAS #WeHearYou #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 20/06/2026
Don’t miss the #MELAS Masterclass at #UMDF #MitoMed! Leading #MitochondrialDisease clinicians and researchers will educate about this #RareDisease, and an individual living with MELAS will share their lived experiences in an interview. #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 17/06/2026
We’re coming full circle at #MitoMed, presenting the results of the mitoARCH study we sponsored at last year’s conference. The study focused on cognitive health, an under-researched aspect of #MitochondrialDisease. Check out the poster tonight or tomorrow! #UMDF #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 15/06/2026
The #UMDF #MitoMed Conference is just around the corner! We’re highlighting our #MitochondrialDisease clinical program, including the fully enrolled Phase 2b PRIZM #MELAS study and the mitoARCH study we sponsored at last year’s conference. Stop by our booth to learn more! #WeHearYou #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 04/06/2026
We had a wonderful few days at #Euromit2026 with many of the leading mitochondrial medicine researchers and clinicians around the world. Thanks for sharing your important work and learning about ours! #PRIZM #MELAS #MitochondrialDisease #Biosky @euromit-2026.bsky.social
031
Tisento Therapeutics @tisentotx.bsky.social · 29/05/2026
Bonjour, Angers! #Euromit2026 starts in two days, and we are energized! Visit us at our booth to learn more about our clinical program in #MitochondrialDisease, including our fully enrolled Phase 2b PRIZM study in #MELAS. #WeHearYou #Biosky @euromit-2026.bsky.social
010
Tisento Therapeutics @tisentotx.bsky.social · 26/05/2026
Next month we’re off to #UMDF #MitoMed Conference, which provides an opportunity for researchers & drug developers like us to meet patients & families. These interactions are critical for meaningful innovation, enabling deeper understanding of lived experiences. #WeHearYou #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 18/05/2026
Looking forward to #Euromit2026 this month! As a Silver Sponsor, we’re proud to support 5 days of cutting-edge science and networking among those committed to improving outcomes for people with #MitochondrialDiseases like #MELAS. @euromit-2026.bsky.social #Biosky www.euromit2026.eu/program-over...
010
Tisento Therapeutics @tisentotx.bsky.social · 30/04/2026
Check out this #Rareatives interview with our VP of Clinical Research, Chad Glasser! He discusses patient-informed #RareDisease trials, the recent #MELAS EL-PFDD meeting led by #MitoAction, and the completion of enrollment in our Ph2b PRIZM study. #Biosky rareatives.com/2026/04/29/t...
011
Reposted by Tisento Therapeutics
Euromit-2026 @euromit-2026.bsky.social · 23/03/2026
@tisentotx.bsky.social is proud to support #euromit2026 as a Silver Sponsor! Our clinical program in the rare #MitochondrialDisease #MELAS is evaluating zagociguat’s effect on symptoms that matter most to patients—including fatigue and cognitive dysfunction. Visit our booth at #Euromit2026#WeHearYou
“Promotional graphic for Tisento Therapeutics. On the left, pink text reads ‘Let’s Connect at #Euromit2026!’. Below, white text states that the company is on a mission to deliver medicines that address what matters most, starting with the rare mitochondrial disease MELAS. On the right, the Tisento Therapeutics logo appears, featuring a stylized mitochondria-like symbol. The background shows a night sky with green and purple aurora borealis. At the bottom left, the website ‘www.tisentotx.com’ is written in green.
021
Tisento Therapeutics @tisentotx.bsky.social · 16/03/2026
It’s #BrainAwarenessWeek! Many #MitochondrialDiseases can have negative implications for brain health. That’s because the brain requires a massive amount of energy, which can only be sufficiently produced when mitochondria are functioning well. #UMDF #Biosky
011
Tisento Therapeutics @tisentotx.bsky.social · 10/03/2026
Learnings from #RareDisease #ClinicalDevelopment are shaping the future of medicine– from sharpened trial design discipline and innovation to deepened collaborations with patients, families, and other stakeholders around the world. #WeHearYou #Biosky www.the-scientist.com/what-rare-di...
010
Tisento Therapeutics @tisentotx.bsky.social · 28/02/2026
Today is #RareDiseaseDay. We stand with the 300 million people globally who live with a rare disease, including those with rare #MitochondrialDiseases like #MELAS. Read stories of #RareDisease heroes: www.rarediseaseday.org/heroes/ #Biosky
020
Tisento Therapeutics @tisentotx.bsky.social · 23/02/2026
There are 6,000+ rare diseases—and expertise and information are often scarce. In health systems designed for common diseases, rare diseases often face inequities. download2.rarediseaseday.org/2025/campaig... #RareDiseaseDay #HealthEquity #MitochondrialDisease #MELAS #Biosky
youtu.be
Rare Disease Day 2026 Official Video
The Official Campaign Video of Rare Disease Day 2026- Learn more and get involved! 👉 https://www.rarediseaseday.org/
000
Tisento Therapeutics @tisentotx.bsky.social · 10/02/2026
The #MELAS Externally Led Patient-Focused Drug Development meeting is today! Hosted by #MitoAction, the event invites those affected by MELAS to share their experiences and be part of shaping #MitochondrialDisease care and treatment. www.mitoaction.org/join-the-cau... #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 05/02/2026
Next week, #MitoAction is hosting an Externally Led Patient-Focused Drug Development meeting dedicated to #MELAS. We’re proud to sponsor this important opportunity to elevate MELAS voices. Virtual event open to all! Register: www.mitoaction.org/join-the-cau... #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 21/01/2026
We believe meaningful innovation starts with listening. That’s why we’re conducting an interview study with adolescents (12-17 years) who are living with #MELAS, a rare #MitochondrialDisease. The final group is enrolling now! www.tisentotx.com/s/Tisento-Ad... #biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 15/01/2026
What will 2026 bring for the #MitochondrialDisease community? Join the @MitoAction town meeting on Friday to hear insights from advocates, clinicians, and industry leaders, including our VP of Program Leadership, Jennifer Chickering. Register here: www.mitoaction.org/resources/20... #Biosky #MELAS
MitoAction Mito Town Meeting | Friday, January 16 | Noon to 2:45pm ET

Hear from Jennifer Chickering, our Vice President of Program Leadership, around 2pm!
000
Tisento Therapeutics @tisentotx.bsky.social · 08/01/2026
We’ve completed enrollment in PRIZM, our global Phase 2b study evaluating our investigational medicine’s impact on fatigue and cognitive function in MELAS – a #RareDisease that currently has no approved treatments. #MitochondrialDisease #Biosky www.tisentotx.com/news/tisento...
010
Tisento Therapeutics @tisentotx.bsky.social · 22/12/2025
This year was filled with momentum and meaningful moments as we worked alongside the #MitochondrialDisease community to amplify MELAS voices and advance our mission to deliver medicines that can address what matters most. Take a look at our #2025Wrapped. #WeHearYou #BioSky
000
Tisento Therapeutics @tisentotx.bsky.social · 08/12/2025
Tune into today’s UMDF Bench-to-Bedside Clinical Trials Update! Chad Glasser, our VP of Clinical Research, will share an update on our Phase 2b PRIZM study in MELAS. #Biosky www.umdf.org/event/umdf-b...
000
Tisento Therapeutics @tisentotx.bsky.social · 27/11/2025
On U.S. Thanksgiving, we want to say thank you to our global community who partner with us on our mission to develop medicines that address what matters most. Thank you to those living with MELAS, their loved ones, advocates, healthcare providers, and our team! #Biosky #Thanksgiving2025
000
Tisento Therapeutics @tisentotx.bsky.social · 20/11/2025
Thanks, @MitoCanada, for creating an accessible, community-friendly summary of our interview study with adults who have MELAS! #MitochondrialDisease #MitoInsights #WeHearYou #Biosky mitocanada.org/signs-sympto...
010
Tisento Therapeutics @tisentotx.bsky.social · 11/11/2025
Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment #Biosky coursesandconferences.wellcomeconnectingscience.org/event/mitoch...
000
Tisento Therapeutics @tisentotx.bsky.social · 03/11/2025
Findings from our #MELAS interview study were recently published in the Journal of Patient-Reported Outcomes. The study highlighted the symptoms & impacts most important to patients and informed our Phase 2b PRIZM study. #MitochondrialDisease #PRO #Biosky www.tisentotx.com/news/tisento...
000
Tisento Therapeutics @tisentotx.bsky.social · 28/10/2025
Meet Roberto and Anna! Married for 30+ years, they support one another through Roberto’s journey with MELAS. We’re honored to support #MitoCon in telling stories of those affected by this #RareDisease. See their story (Italian w/ English subtitles): youtu.be/mwkczr_QDxg #Biosky
youtu.be
MELAS | Teaser testimonianza di Anna e Roberto
000
Tisento Therapeutics @tisentotx.bsky.social · 23/10/2025
Meet Morena! She’s a mom and a retired nurse, loves deeply connecting with people, and lives with #MELAS. We’re honored to support #MitoCon in telling stories of those affected by this #RareDisease. See Morena’s story (Italian w/ English subtitles): youtu.be/bFciPejLNPg #Biosky
youtu.be
MELAS | Teaser testimonianza di Morena
YouTube video by Mitocon Odv
010
Tisento Therapeutics @tisentotx.bsky.social · 25/09/2025
Last call for our PRIZM clinical study in #MELAS! We’re expecting to complete enrollment in the next few weeks. Those who are interested in participating at one of our sites around the world can find out more by talking to their doctor. #ClinicalResearch #MitochondrialDisease www.tisentotx.com/prizm
000
Tisento Therapeutics @tisentotx.bsky.social · 22/09/2025
It was so inspiring to see so many people around the world sharing stories and raising awareness about #MitochondrialDisease during #WorldMitoWeek2025. We’re honored to be part of such a wonderful global community. #DecodeTheMitoPuzzle #LightUpForMito #BioSky
010
Tisento Therapeutics @tisentotx.bsky.social · 20/09/2025
To us, #LightUpForMito is personal. While monuments and landmarks around the world are lit up in green, we’re lighting up our homes, our pets, and ourselves. We stand with the #MitochondrialDisease community! #WorldMitoWeek2025 #DecodeThePuzzle #Biosky
010
Tisento Therapeutics @tisentotx.bsky.social · 20/09/2025
Tonight, landmarks, buildings & monuments around the world will light up in GREEN to shine a light on #MitochondrialDiseases. This display raises visibility, sparks conversations & shows solidarity with the mito community. #LightUpForMito #WorldMitoWeek2025 #Biosky mitopatients.org/light-up-for...
000
Tisento Therapeutics @tisentotx.bsky.social · 19/09/2025
Your voice matters for those affected by #MitochondrialDisease! International Mito Patients (IMP) has practical tips and useful resources for getting involved during #WorldMitoWeek2025 and beyond! #DecodeTheMitoPuzzle #Biosky mitopatients.org/mito-week/
000
Tisento Therapeutics @tisentotx.bsky.social · 18/09/2025
#MELAS can affect multiple organ systems and frequently causes a range of severe and burdensome symptoms. We are working on what could be the first treatment for this devastating disease through our PRIZM MELAS study. #WorldMitoWeek2025 #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 17/09/2025
Collaboration among researchers, clinicians & patients translates science into real-world impact for those with #MitochondrialDisease. We’re proud to be part of this network with our PRIZM #MELAS clinical study. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky www.tisentotx.com/prizm
000
Tisento Therapeutics @tisentotx.bsky.social · 16/09/2025
Mitochondria are known as “the powerhouse of the cell,” generating ~90% of the energy our bodies need and playing a critical role in many different bodily systems and organs. #MitochondrialDiseases have broad and debilitating consequences. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky
000
Tisento Therapeutics @tisentotx.bsky.social · 15/09/2025
#WorldMitoWeek2025 starts today! This advocacy week is intended to raise awareness about #MitochondrialDiseases with a goal of improving the lives of people affected by these diseases. Join us in supporting this global community! #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
001